3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
19
Small Cell Lung Carcinoma
10
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
6
Fallopian Tube Neoplasms
6
Urinary Bladder Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Gallbladder Neoplasms
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Stomach Neoplasms
3
Sarcoma
3
Mouth Neoplasms
3
Mesothelioma, Malignant
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma
3
Urethral Neoplasms
2
Triple Negative Breast Neoplasms
2
Testicular Neoplasms
2
Seminoma
2
Salivary Gland Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Interventions
Filgrastim
10
Cyclophosphamide
8
Granulocyte Colony-Stimulating Factor
6
Melphalan
5
Busulfan
5
Vincristine
4
Topotecan
4
Temozolomide
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Ifosfamide
4
Etoposide
4
Thiotepa
3
Radiotherapy
3
Mesna
3
Itraconazole
3
Doxorubicin
3
Cisplatin
3
Carboplatin
3
sargramostim
2
fludarabine
2
Therapeutics
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Drug Therapy
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
trioctyl phosphine oxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Wilms Tumor
×
Platinum
×
Clear all
NCT05765084
2024-05-16
Immuno-MESODEC
University Hospital, Antwerp
Phase 1/2
Recruiting
15 enrolled